BP821
(−)-Nicotine hydrogen tartrate salt dihydrate
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 6019-06-3
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | BP821-100-MG | In Stock | ₹ 21,401.03 |
BP821 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 21,401.03
GST (18%): ₹ 3,852.185
Total Price: ₹ 25,253.215
grade
pharmaceutical primary standard
Quality Level
100
API family
nicotine
form
powder
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
InChI
1S/C17H15ClN2O3/c1-9(2)16(22)19-11-4-5-14(21)12(8-11)17-20-13-7-10(18)3-6-15(13)23-17/h3-9,20H,1-2H3,(H,19,22)/b17-12-
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Nicotine bitartrate dihydrate | Supelco | ₹ 24,496.98 | |
| | Nicotine ditartrate dihydrate | Sigma Aldrich | ₹ 16,107.60 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: (−)-Nicotine hydrogen tartrate salt dihydrate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Nicotine Resinate Medicated Chewing Gum
- Packaging: Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P262 - P280 - P301 + P310 + P330 - P302 + P352 + P310 - P304 + P340 + P311 - P314
Hazard Classifications
Acute Tox. 1 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - STOT RE 1
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
Quality Level: 100
API family: nicotine
form: powder
shelf life: limited shelf life, expiry date on the label
manufacturer/tradename: BP
application(s): pharmaceuticalpharmaceutical small molecule
format: neat
storage temp.: 2-8°C
InChI: 1S/C17H15ClN2O3/c1-9(2)16(22)19-11-4-5-14(21)12(8-11)17-20-13-7-10(18)3-6-15(13)23-17/h3-9,20H,1-2H3,(H,19,22)/b17-12-
grade:
pharmaceutical primary standard
Quality Level:
100
API family:
nicotine
form:
powder
shelf life:
limited shelf life, expiry date on the label
manufacturer/tradename:
BP
application(s):
pharmaceuticalpharmaceutical small molecule
format:
neat
storage temp.:
2-8°C
InChI:
1S/C17H15ClN2O3/c1-9(2)16(22)19-11-4-5-14(21)12(8-11)17-20-13-7-10(18)3-6-15(13)23-17/h3-9,20H,1-2H3,(H,19,22)/b17-12-
grade: pharmaceutical primary standard
Quality Level: __
API family: doxepin
form: solid
shelf life: limited shelf life, expiry date on the label
manufacturer/tradename: BP
application(s): pharmaceuticalpharmaceutical small molecule
format: mixture
storage temp.: 2-8°C
InChI: 1S/C19H21NO.ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19;/h3-6,8-12H,7,13-14H2,1-2H3;1H/b17-11+;
grade:
pharmaceutical primary standard
Quality Level:
__
API family:
doxepin
form:
solid
shelf life:
limited shelf life, expiry date on the label
manufacturer/tradename:
BP
application(s):
pharmaceuticalpharmaceutical small molecule
format:
mixture
storage temp.:
2-8°C
InChI:
1S/C19H21NO.ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19;/h3-6,8-12H,7,13-14H2,1-2H3;1H/b17-11+;
grade: pharmaceutical primary standard
Quality Level: __
API family: betahistine
form: solid
shelf life: limited shelf life, expiry date on the label
manufacturer/tradename: BP
application(s): pharmaceuticalpharmaceutical small molecule
format: neat
storage temp.: 2-8°C
InChI: 1S/C8H12N2.2ClH/c1-9-7-5-8-4-2-3-6-10-8;;/h2-4,6,9H,5,7H2,1H3;2*1H
grade:
pharmaceutical primary standard
Quality Level:
__
API family:
betahistine
form:
solid
shelf life:
limited shelf life, expiry date on the label
manufacturer/tradename:
BP
application(s):
pharmaceuticalpharmaceutical small molecule
format:
neat
storage temp.:
2-8°C
InChI:
1S/C8H12N2.2ClH/c1-9-7-5-8-4-2-3-6-10-8;;/h2-4,6,9H,5,7H2,1H3;2*1H
grade: pharmaceutical primary standard
Quality Level: __
API family: alfuzosin
form: solid
shelf life: limited shelf life, expiry date on the label
manufacturer/tradename: BP
application(s): pharmaceuticalpharmaceutical small molecule
format: neat
storage temp.: 2-8°C
InChI: 1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H
grade:
pharmaceutical primary standard
Quality Level:
__
API family:
alfuzosin
form:
solid
shelf life:
limited shelf life, expiry date on the label
manufacturer/tradename:
BP
application(s):
pharmaceuticalpharmaceutical small molecule
format:
neat
storage temp.:
2-8°C
InChI:
1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H